Physician

Sara Duke, MD

According to 2025 Medicare claims, Sara Duke, MD (NPI: 1306089065) practices ophthalmology in the Coeur d'Alene, ID market, with the plurality of this provider's patient population coming from Kootenai, ID. This provider's primary affiliated billing organization is NORTH IDAHO EYE INSTITUTE P A (NPI: 1699811646; TIN: 820448111) and primary practice location at 83814-2540. Duke is affiliated with the Kootenai Accountable Care, LLC (ACO ID: A3621), participating under the MSSP model.

Duke's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 916 traditional Medicare patients, billed 8,370 HCPCS/CPT codes, and received $771,235 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 1,360 prescription claims across 361 beneficiaries totaling $117,612 in drug costs, led by Restasis (Cyclosporine). 2019 DME data shows 15 claims. Open Payments data shows 3 records totaling $56. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $47,267 to $117,612. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	750	2,783	$330,778
2016	772	3,546	$511,807
2017	683	2,685	$432,990
2018	992	4,672	$779,968
2019	1,054	5,364	$922,520
2020	794	4,169	$706,458
2021	983	4,937	$726,491
2022	933	4,486	$652,458
2023	957	4,959	$666,424
2024	916	8,370	$771,235

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	265	1,022	$47,267
2016	327	1,231	$72,784
2017	327	1,184	$60,468
2018	443	1,744	$130,235
2019	471	2,004	$182,431
2020	312	1,223	$107,572
2021	322	1,194	$127,978
2022	328	1,179	$404,033
2023	344	1,210	$195,006
2024	361	1,360	$117,612

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	15	15	$1,115
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92014	Established patient complete exam of visual system	581	613	$78
92012	Established patient problem focused exam of visual system	249	353	$58
92134	Imaging of retina	308	710	$28
92133	Imaging of optic nerve	192	196	$23
92136	Measurement of corneal curvature and depth of eye	146	368	$17

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	41	2,430	$49,662
Cyclosporine	Cyclosporine	28	2,400	$21,597
Rhopressa	Netarsudil Mesylate	13	774	$7,909
Latanoprost	Latanoprost	476	34,477	$5,727
Bromfenac Sodium	Bromfenac Sodium	23	620	$3,072

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$56	Oyster Point Pharma, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sara Duke, MD?

Tedicare shows public-source Medicare data for Sara Duke, MD (NPI 1306089065), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sara Duke, MD have ACO affiliation data?

Sara Duke, MD is shown with ACO affiliation data for Kootenai Accountable Care, LLC (MSSP, ACO ID A3621).

What billing organization is linked to Sara Duke, MD?

Sara Duke, MD is linked to NORTH IDAHO EYE INSTITUTE P A (billing NPI 1699811646) in the available physician profile data.

Does Sara Duke, MD have Open Payments data?

Sara Duke, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.